The Aurobindo Generis Group presented, through a statement, its new CEO - Luís Abrantes.

Luís Abrantes has a degree in Business Management from Iscte and has more than 27 years of professional experience, 15 of which in the generic pharmaceutical industry.

He started his career at Arthur Andersen, having worked in different sectors, always in the financial area. Currently, he was working as Chief Financial Officer at the Teva group, in Portugal.

Iscte Business School congratulates its alumnus, wishing him the greatest success at this challenging position.

Source: Netfarma